Fundz

U.S. Stem Cell, Inc. reported raising $190,000 in an initial SEC Form D filing

PRIVATEFeb 22, 2021

Amount Raised

$190,000

$190,000 sold, per SEC Form D (first sale Feb 22, 2021)

Round Type

Seed

SunriseHealthcare

Quick answer

U.S. Stem Cell, Inc. raised $190,000 in a Seed round, dated February 22, 2021. U.S. Stem Cell, Inc. is based in Sunrise, Florida, United States.

How much did U.S. Stem Cell, Inc. raise?
U.S. Stem Cell, Inc. raised $190,000 in a Seed round on February 22, 2021.
Where is U.S. Stem Cell, Inc. based and how big is it?
U.S. Stem Cell, Inc. is based in Sunrise, Florida, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as U.S. Stem Cell, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Quoin Pharmaceuticals, Inc. raised $2M (Seed) on April 8, 2021.
  • National Green Biomed Ltd. raised $16K (Pre-Seed) on April 8, 2021.
  • Rightway raised $69M on April 7, 2021.
  • INTRINSIC THERAPEUTICS raised $38M on April 7, 2021.
  • DepYmed raised $5.5M on April 7, 2021.
  • Vivani Medical, Inc. raised $28M on April 7, 2021.

Who to call at U.S. Stem Cell, Inc., and when

A new round usually means U.S. Stem Cell, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day U.S. Stem Cell, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at U.S. Stem Cell, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at U.S. Stem Cell, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

U.S. Stem Cell, Inc.

Location

13794 NW 4TH STREET

Sunrise, Florida, United States

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment U.S. Stem Cell, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for U.S. Stem Cell, Inc.'s next move

See what Strategic adds

U.S. Stem Cell, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.